• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病中心血管疾病的临床流行病学

The clinical epidemiology of cardiovascular disease in chronic kidney disease.

作者信息

Shik John, Parfrey Patrick S

机构信息

Health Sciences Centre, Memorial University of Newfoundland, St John's, Newfoundland, Canada.

出版信息

Curr Opin Nephrol Hypertens. 2005 Nov;14(6):550-7. doi: 10.1097/01.mnh.0000170752.64150.88.

DOI:10.1097/01.mnh.0000170752.64150.88
PMID:16205474
Abstract

PURPOSE OF REVIEW

To review recent publications concerning the epidemiology and management of cardiovascular disease in the stages of chronic kidney disease.

RECENT FINDINGS

Chronic kidney disease is a state of increased risk for atherosclerotic and cardiomyopathic disease. The mechanisms of cardiovascular disease probably change with the different stages of chronic kidney disease. Both proteinuria and decreased glomerular filtration rate are probably independent cardiovascular disease risk factors, although the impact of the latter is modest. Traditional risk factors are important predictors of cardiovascular disease in chronic kidney disease. Recent randomized controlled trials and cohort studies have supported interventions for smoking cessation, blood pressure control, renin-angiotensin system blockade, the correction of lipid abnormalities, and utilizing antiplatelet agents. Some uraemia-related risk factors predict the development of cardiovascular disease, particularly hypoalbuminaemia, inflammation, anaemia, and homocysteinaemia. However, randomized controlled trials of anaemia correction and of an increased quantity of dialysis were negative.

SUMMARY

The role of oxidant stress, divalent ion abnormalities, various lipid abnormalities and other potential factors require further investigation. To determine whether these uraemia-related factors are markers of cardiovascular disease risk or are actually cardiotoxic requires additional randomized controlled trials.

摘要

综述目的

综述近期有关慢性肾脏病各阶段心血管疾病流行病学及管理的出版物。

最新发现

慢性肾脏病是动脉粥样硬化性疾病和心肌病风险增加的一种状态。心血管疾病的机制可能随慢性肾脏病的不同阶段而变化。蛋白尿和肾小球滤过率降低可能都是独立的心血管疾病危险因素,尽管后者的影响较小。传统危险因素是慢性肾脏病中心血管疾病的重要预测指标。近期的随机对照试验和队列研究支持针对戒烟、血压控制、肾素 - 血管紧张素系统阻断、纠正脂质异常以及使用抗血小板药物的干预措施。一些与尿毒症相关的危险因素可预测心血管疾病的发生,特别是低白蛋白血症、炎症、贫血和高同型半胱氨酸血症。然而,贫血纠正和增加透析量的随机对照试验结果为阴性。

总结

氧化应激、二价离子异常、各种脂质异常及其他潜在因素的作用需要进一步研究。要确定这些与尿毒症相关的因素是心血管疾病风险的标志物还是实际具有心脏毒性,还需要更多的随机对照试验。

相似文献

1
The clinical epidemiology of cardiovascular disease in chronic kidney disease.慢性肾脏病中心血管疾病的临床流行病学
Curr Opin Nephrol Hypertens. 2005 Nov;14(6):550-7. doi: 10.1097/01.mnh.0000170752.64150.88.
2
Epidemiology and prevention of cardiovascular complication in chronic kidney disease patients.慢性肾病患者心血管并发症的流行病学与预防
Semin Nephrol. 2004 Sep;24(5):417-22. doi: 10.1016/j.semnephrol.2004.06.012.
3
[Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].[肾小球滤过率与心血管风险:预后及治疗意义]
G Ital Nefrol. 2008 Jan-Feb;25(1):21-31.
4
Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease.无需透析的慢性肾脏病与心血管疾病的流行病学
Curr Opin Nephrol Hypertens. 2006 May;15(3):296-302. doi: 10.1097/01.mnh.0000222698.30207.aa.
5
Chronic kidney disease: effects on the cardiovascular system.慢性肾脏病:对心血管系统的影响
Circulation. 2007 Jul 3;116(1):85-97. doi: 10.1161/CIRCULATIONAHA.106.678342.
6
Kidney disease as an independent risk factor for cardiovascular events.
J Ren Nutr. 2005 Jan;15(1):99-104. doi: 10.1053/j.jrn.2004.09.032.
7
[Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].[慢性肾脏病中的高血压、血脂异常与心血管风险]
Ital Heart J Suppl. 2004 Jun;5(6):436-44.
8
Epidemiology of cardiovascular risk in patients with chronic kidney disease.慢性肾脏病患者心血管风险的流行病学
Nephrol Dial Transplant. 2003 Aug;18 Suppl 7:vii2-9. doi: 10.1093/ndt/gfg1072.
9
Early origins of cardiovascular disease in pediatric chronic kidney disease.儿科慢性肾脏病中心血管疾病的早期起源。
Ren Fail. 2010 Jan;32(1):1-9. doi: 10.3109/08860220903288534.
10
Cardiovascular disease in patients with chronic kidney disease. A clinical review.慢性肾病患者的心血管疾病。一项临床综述。
Minerva Urol Nefrol. 2007 Sep;59(3):281-97.

引用本文的文献

1
Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan.台湾地区一项基于全国人口的研究:透析治疗的终末期肾病患者心房颤动风险增加。
Medicine (Baltimore). 2016 Jun;95(25):e3933. doi: 10.1097/MD.0000000000003933.
2
Cholesterol Metabolism in CKD.慢性肾脏病中的胆固醇代谢
Am J Kidney Dis. 2015 Dec;66(6):1071-82. doi: 10.1053/j.ajkd.2015.06.028. Epub 2015 Sep 1.
3
PAI-1 and kidney fibrosis.纤溶酶原激活物抑制剂-1与肾纤维化
Front Biosci (Landmark Ed). 2009 Jan 1;14(6):2028-41. doi: 10.2741/3361.
4
Correlates of N-terminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African American Study of Kidney Disease and Hypertension.非裔美国高血压慢性肾病患者N末端前体脑钠肽的相关因素:非裔美国人肾病与高血压研究
Am J Nephrol. 2009;29(4):292-8. doi: 10.1159/000159276. Epub 2008 Sep 29.